Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06045962

Optimal Stent Duration After Ureteroscopy

Effect of Three vs Seven Day Ureteral Stent Removal After Ureteroscopy on Stent Related Symptoms

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
172 (estimated)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine how soon ureteral stents can be safely removed following surgery.

Detailed description

The rationale for this study is to determine if there is a difference in symptoms or complications among patients undergoing uncomplicated ureteroscopy for stone removal with shorter indwelling stent duration. Currently there are only a few small studies exploring the optimal duration of stent placement after stent placement and no multicenter randomized control trials. The investigation aim is to determine if earlier ureteral stent removal will reduce urinary symptoms after stent removal and improve quality of life without increasing risk of negative side effects. Using questionnaires for stent related symptoms the researchers will assess stent indwelling time effect on patient reported side effects.

Conditions

Interventions

TypeNameDescription
DEVICEUreteral stentUsed to open the ureter and help the kidney drain

Timeline

Start date
2023-11-01
Primary completion
2026-09-01
Completion
2026-09-01
First posted
2023-09-21
Last updated
2025-10-03

Locations

11 sites across 2 countries: United States, Canada

Regulatory

Source: ClinicalTrials.gov record NCT06045962. Inclusion in this directory is not an endorsement.

Optimal Stent Duration After Ureteroscopy (NCT06045962) · Clinical Trials Directory